Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a leader in the development of exoskeletons for medical and industrial applications, has announced a reverse stock split. This strategic move involves exchanging 1 share for every 15 shares owned by shareholders. The reverse stock split is aimed at managing the company’s stock structure and enhancing its marketability.
The reverse stock split, initially set for May 27, 2025, has been rescheduled to take effect on June 2, 2025. On this date, EKSO’s common stock will begin trading on The Nasdaq Capital Market on a split-adjusted basis, continuing under the symbol “EKSO” but with a new CUSIP number, 282644 400. This adjustment will decrease the total number of outstanding shares from approximately 35.5 million to around 2.4 million.
Despite the reverse stock split, the par value per share will remain unchanged. This move aims to consolidate shares, potentially increasing the stock price and making it more attractive to investors. Currently, EKSO’s stock is priced at $0.2524, having decreased by 13.15%, or $0.0382. The stock has seen fluctuations between $0.25 and $0.2893 in today’s trading session.
Over the past year, EKSO’s stock has experienced a high of $1.53 and a low of $0.245. The company’s market capitalization is approximately $7.33 million, with a trading volume of 1,665,690 shares. The reverse stock split is expected to help stabilize the stock price and improve its market standing, potentially attracting more investors.
